Sumitomo Chemical India Limited engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally. It also offers crop protection products, such as insecticides, herbicides, fungicides, and miticides; animal nutrition and plant growth regulators; fumigants and rodenticides; weedicides; and biological products. The company exports its products. Sumitomo Chemical India Limited was incorporated in 2000 and is headquartered in Mumbai, India. The company is a subsidiary of Sumitomo Chemical Company Limited.
Revenue projections:
Revenue projections for SUMICHEM SUMICHEM's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.
Financial Ratios:
currentRatio
3.121000
forwardPE
33.105568
debtToEquity
1.820000
earningsGrowth
-0.075000
revenueGrowth
-0.059000
grossMargins
0.400940
operatingMargins
0.216470
trailingEps
10.870000
forwardEps
0.000000
Sumitomo Chemical India Limited's current ratio of 3.121 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, Sumitomo Chemical India Limited can comfortably cover its liabilities, reflecting a strong financial outlook. SUMICHEM's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins. SUMICHEM's positive gross and operating margins suggest that the company is operating profitably. These strong margins indicate effective cost management and revenue generation, contributing to a solid financial foundation.
Price projections:
Price projections for SUMICHEM Over time, SUMICHEM's price projections have steadily declined, reflecting reduced confidence in the company's future performance. The downward revisions suggest analysts are becoming more conservative in their assessments.
Recommendation changes over time:
Recommendations trend for SUMICHEM
Analysts have maintained a buy bias for SUMICHEM, which could prompt investors to consider the stock as a viable investment. With this positive outlook, SUMICHEM is positioned as an attractive option for those looking to park their money in a stable and potentially lucrative company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An analysis of how sticky inflation and natural disaster risks are creating...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.